Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reversible posterior leukoencephalopathy syndrome and intravenous bevacizumab.

× No keyword cloud information.

6 in total

1. Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma.

Authors: Liesbeth M Kager; Marie-Jose Kersten; Raoul Peter Kloppenborg; Rien Van Oers; Bert-Jan Van den Born
Journal: BMJ Case Rep Date: 2009-10-12

2. Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.

Authors: Christina A K Kim; Julie Price-Hiller; Quincy S Chu; Keith Tankel; Ron Hennig; Michael B Sawyer; Jennifer L Spratlin
Journal: Invest New Drugs Date: 2014-05-23 Impact factor: 3.850

3. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer.

Authors: Wei Wang; Li-Rong Zhao; Xiu-Qiang Lin; Fen Feng
Journal: World J Gastroenterol Date: 2014-06-07 Impact factor: 5.742

4. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.

Authors: Yongen Chang; Gilbert Mbeo; Susan J Littman
Journal: J Gastrointest Cancer Date: 2012-09

Review 5. Posterior reversible encephalopathy syndrome induced by anti-VEGF agents.

Authors: Camille Tlemsani; Olivier Mir; Pascaline Boudou-Rouquette; Olivier Huillard; Karin Maley; Stanislas Ropert; Romain Coriat; François Goldwasser
Journal: Target Oncol Date: 2011-11-17 Impact factor: 4.493

6. Atypical reversible leucoencephalopathy syndrome after bevacizumab/folfox regimen for metastatic colon cancer.

Authors: Narimane Salmi; Ibrahim Elghissassi; Khadija Bellahammou; Asmaa Lakhdissi; Hind Mrabti; Hassan Errihani
Journal: Case Rep Oncol Med Date: 2014-10-21

6 in total